Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

House votes to permanently repeal 2.3% medical device tax

The U.S. House of Representatives voted to repeal the 2.3 percent medical device tax that was implemented as part of the Affordable Care Act. The House voted 283 to 132, with 57 Democrats joining Republicans.

Thumbnail

House permanently repeals 2.3% medical device tax

The U.S. House of Representatives voted to repeal the 2.3 percent medical device tax that was implemented as part of the Affordable Care Act. The House voted 283 to 132, with 57 Democrats joining Republicans.

Recruitment incentives for cardiologists at ‘unprecedented’ levels

Invasive cardiologists ranked No. 1 of all subspecialties with an average starting salary of $590,000, according to Merritt Hawkins’ 2018 report. And that's just the base amount—more money can be earned with quality and productivity incentives.

Thumbnail

40% of breast cancer patients struggle to afford treatment

Nearly 40 percent of women find their breast cancer treatment unaffordable, according to a large-scale study published in Cancer this month—but radiation oncologists are better than some at communicating financial difficulties to their patients.

Thumbnail

George H.W. Bush’s cardiologist killed in shooting

Former President George H.W. Bush’s cardiologist was killed on July 20 in an apparent bicycle drive-by shooting near the Texas Medical Center (TMC) in Houston.

Thumbnail

ACC names Timothy W. Attebery as CEO

The American College of Cardiology (ACC) announced the selection of Timothy W. Attebery, MBA, to serve as its chief executive officer, effective Sept. 1.

Thumbnail

Boston Scientific acquires Claret Medical in $250M deal

Boston Scientific announced its acquisition of Santa Rosa, California-based Claret Medical in a transaction that includes $220 million upfront and an additional potential reimbursement-based milestone payment of up to $50 million. The deal is expected to close before the end of the year.

Thumbnail

New blood test can diagnose melanomas with 79% accuracy

A group of Australian researchers have developed a blood test that can accurately detect melanoma with 79 percent accuracy in its earliest stages. Results of their study were published on July 17 in Onocotarget.